enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. GLP-1 receptor agonist - Wikipedia

    en.wikipedia.org/wiki/GLP-1_receptor_agonist

    As a result, different GLP-1 agonist drugs are modified in various ways to extend the half-life, resulting in drugs that can be dosed multiple times per day, daily, weekly, or less often. [29] Most synthetic GLP-1 agonists are delivered via subcutaneous injection , which is a barrier to their use and reason for discontinuation. [ 37 ]

  3. Dapoxetine - Wikipedia

    en.wikipedia.org/wiki/Dapoxetine

    Its fast-acting property makes it suitable for the treatment of PE, but not as an antidepressant. [7] Originally created by Eli Lilly pharmaceutical company, dapoxetine was sold to Johnson & Johnson in 2003 and submitted as a New Drug Application to the USFood and Drug Administration (FDA) for the treatment of PE in 2004. [8]

  4. Lixisenatide - Wikipedia

    en.wikipedia.org/wiki/Lixisenatide

    Lixisenatide is a member of the class of glucagon-like peptide-1 receptor agonist drugs, each of which activates the GLP-1 receptor. GLP-1 is a hormone that helps pancreatic beta cells to secrete insulin in response to high blood sugar. Because it works like the normal hormone, insulin is only secreted when blood sugar is high.

  5. Novolin - Wikipedia

    en.wikipedia.org/wiki/Novolin

    Novolin is the brand name of three distinct insulin-containing products [1] manufactured by Novo Nordisk: [2] Novolin 70/30, an insulin preparation containing mixed NPH and regular insulin, respectively; Novolin N, an insulin preparation containing NPH insulin; Novolin R, an insulin preparation containing regular insulin

  6. US FDA panel votes against Novo Nordisk's weekly insulin in ...

    www.aol.com/news/us-fda-panel-votes-against...

    Novo is aiming to be the first to hit the market with a weekly insulin product, offering an alternative for patients with type 1 and type 2 diabetes who now depend on multiple daily injections.

  7. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    GLP-1 regulates digestion and blood sugar. The small intestine releases GLP-1 when food is eaten. It reduces hunger, signals fullness, stimulates insulin, and inhibits glucagon, maintaining glucose levels. Semaglutide is a glucagon-like peptide-1 receptor agonist. [14] [15] [16] The drug decreases blood sugar levels.

  8. Forxiga ™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes Forxiga, a once-daily oral agent, provides ...

  9. Drug class - Wikipedia

    en.wikipedia.org/wiki/Drug_class

    A drug class is a group of medications and other compounds that share similar chemical structures, act through the same mechanism of action (i.e., binding to the same biological target), have similar modes of action, and/or are used to treat similar diseases.